THE US Food and Drug
Administration has found links
between 12 cases of serious eye
infections and Avastin
(bevacizumab) injections.
According to reports the dozen
eye infection patients in Miami had
all recently received an ocular
Avastin injection to treat wet
macular degeneration.
Investigations traced the cause
back to a pharmacy which had
repackaged the drug from its
sterile 4ml vials to individual 1ml
syringes.
“Health care professionals should
be aware that repackaging sterile
drugs without proper aseptic
technique can compromise
product sterility, potentially
putting the patient at risk for
microbial infections,” the FDA said.The above article was sent to subscribers in Pharmacy Daily's issue from 01 Sep 11 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Sep 11
MAYNE Pharma Group Limited has filed a patent infringement suit against Sun Pharmaceutical Industries Ltd and Inc., in the United States District Court, according to yesterday’s ASX announcement.
PHARMACY Connect 2024 conference will feature a provocative ‘Great Debate’ during the Harm Minimisation Workshop on Thu 05 Sep at the Hyatt Regency in Sydney.
LTR Pharma Limited has successfully raised $10.5 million through a share placement to sophisticated and new institutional investors, significantly surpassing initial demand.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.